Workflow
Norovirus oral pill vaccine
icon
Search documents
Vaxart (VXRT) Update / Briefing Transcript
2025-06-11 13:30
Vaxart (VXRT) Update / Briefing June 11, 2025 08:30 AM ET Speaker0 Greetings, and welcome to the Vaxart Neurovirus Phase one Top Line Results Conference Call. A question and answer session will follow management's opening remarks. Investors may submit written questions to irvaxart.com. As a reminder, this conference is being recorded. I would now like to turn the call over to your host, Ed Berg, Senior Vice President and General Counsel. Please go ahead. Speaker1 Good afternoon and welcome to today's call. ...
Vaxart(VXRT) - 2025 Q1 - Earnings Call Transcript
2025-05-13 21:32
Vaxart (VXRT) Q1 2025 Earnings Call May 13, 2025 04:30 PM ET Company Participants Edward Berg - Senior Vice President and General CounselSteven Lo - CEO , President & DirectorJames Cummings - Chief Medical OfficerSean Tucker - Founder & Chief Scientific OfficerPhillip Lee - Chief Financial OfficerCheng Li - Director - Equity ResearchMayank Mamtani - Senior Managing Director & Group Head of HealthcareLiang Cheng - Senior Research Associate Operator Greetings. Welcome to Vaxart Business Update and First Quart ...
Vaxart(VXRT) - 2025 Q1 - Earnings Call Transcript
2025-05-13 21:30
Vaxart (VXRT) Q1 2025 Earnings Call May 13, 2025 04:30 PM ET Speaker0 Greetings. Welcome to Vaxart Business Update and First Quarter twenty twenty five Financial Results Conference Call. A question and answer session will follow management's opening remarks. Individual investors may submit written questions to vaxart.com. As a reminder, this conference is being recorded. I would now like to turn the webcast over to your host, Ed Berg, Senior Vice President and General Counsel. Speaker1 Good afternoon, and w ...